Adalimumab, etanercept, infliximab, rituximab and abatacept for the treatment of rheumatoid arthritis after the failure of a TNF inhibitor

Technology appraisal guidance
Reference number: TA195
Published: 25 August 2010

Rheumatoid arthritis - drugs for treatment after failure of a TNF inhibitor: final appraisal determination

Rheumatoid arthritis - drugs for treatment after failure of a TNF inhibitor: final appraisal determination

Rheumatoid arthritis - drugs for treatment after failure of a TNF inhibitor: final appraisal determination
24 June 2010
(323.57 Kb 34 sec)

Adobe Acrobat reader required.

Adobe Acrobat reader required.

This page was last updated: 24 June 2010